Molecular studies have convincingly demonstrated that SLX4IP colocalizes with telomeres in ALT-positive cancer cells but not in telomerase-positive cells (Dejardin and Kingston, 2009; Panier et al., 2019; Robinson et al., 2020; Robinson et al., 2021). This evidence concerns the gene GPT and cancer.